Study: Link Between Stress and Cancer Returning
STUDY SUGGESTS A LINK BETWEEN STRESS AND CANCER COMING BACK January, 2021 National Cancer Institute Modified For Style For many cancer survivors, their worst nightmare is finding out that their
Importance of Maintaining Doctor-Patient Dialogue & Securing Second Opinions
Video Presented By Dr. Douglas B. Evans, MD, FACS Chair of The Department of Surgery at the Medical College of Wisconsin and Professor of Surgery at the Donald C. Ausman
The Link Between Opioid Medication and Pancreatic Cancer
Based Upon News Release January 7, 2021 Rush University Medical Center Edited For Style and Length Research Led By Faraz Bishehsari , MD, PhD, Suggests Opioid Use Might Increase A
Drug Compound Attacks “Super Enhancers” in The Stroma Cocoon
Compound Derived From Thunder God Vine Could Help Pancreatic Cancer Patients TGen Study Indicates Drug Attacks “Super Enhancers” in The Stroma Cocoon That Hides The Tumor From The Immune System
Scientific Achievement Award
Dr. Von Hoff To Receive Inaugural AACR Scientific Achievement Award Recognized For Sustained Scientific Innovation and Accomplishments Based On A TGen Press Release November 25, 2020 The American Association for
Their Voices Will Never Go Silent
They Earned Their Wings, But Their Voices Will Never Go Silent Co-Written By: Tony Subia and Julia Brabant October 18,2020 They shared a common goal. A kindred spirit to live
3 Ways Cancer Can Spread To Other Parts of The Body
What is Metastasis? When The Primary Cancer Spreads From Where It Began to Surrounding Tissue and/or Body Organs Contributing Writer: Tony Subia October 2, 2020 A Metastatic Malignant Tumor is
Steve Stagner: The Importance of Philanthropy in All Seasons
Steve Was A Previous Executive Chair and CEO of Mattress Firm. Stagner is A Strong Ambassador of the Seena Magowitz Foundation With everything going on in the world this year,
Shows Promise For A Certain Type of Pancreatic Cancer
A New Drug From Merus, A Drug Company Specializing in Immo-Oncology Therapeutics Targets A Genetic Abnormality Called NRG1 Fusion Found in Some Pancreatic Cancers. The Drug is Currently in Clinical
Immunotherapy COMBAT Clinical Trial
HonorHealth and TGen Investigators Encouraged With Results and Hope To Show Patient Benefit in Larger Studies Based Upon TGen Press Release Edited For Style and Presentation August 22, 2020 Working